194 related articles for article (PubMed ID: 23418928)
1. Immune cell profile of sentinel lymph nodes in patients with malignant melanoma - FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome.
Mohos A; Sebestyén T; Liszkay G; Plótár V; Horváth S; Gaudi I; Ladányi A
J Transl Med; 2013 Feb; 11():43. PubMed ID: 23418928
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction.
Lee JH; Chen Y; Chan JL; Qian YW; Goydos JS
Cancer Immunol Immunother; 2011 May; 60(5):685-92. PubMed ID: 21327637
[TBL] [Abstract][Full Text] [Related]
3. High FOXP3+ regulatory T-cell density in the sentinel lymph node is associated with downstream non-sentinel lymph-node metastasis in gastric cancer.
Lee HE; Park DJ; Kim WH; Kim HH; Lee HS
Br J Cancer; 2011 Jul; 105(3):413-9. PubMed ID: 21730981
[TBL] [Abstract][Full Text] [Related]
4. Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.
Ma MW; Medicherla RC; Qian M; Vega-Saenz de Miera E; Friedman EB; Berman RS; Shapiro RL; Pavlick AC; Ott PA; Bhardwaj N; Shao Y; Osman I; Darvishian F
Mod Pathol; 2012 Jul; 25(7):1000-10. PubMed ID: 22425909
[TBL] [Abstract][Full Text] [Related]
5. Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma.
Elliott B; Scolyer RA; Suciu S; Lebecque S; Rimoldi D; Gugerli O; Musat E; Sharma RN; Lienard D; Keilholz U; Testori A; Eggermont A; MacKie R; Robert C; Cook M; Thompson JF; Angevin E; Spatz A;
Clin Cancer Res; 2007 Jul; 13(13):3825-30. PubMed ID: 17606713
[TBL] [Abstract][Full Text] [Related]
6. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
[TBL] [Abstract][Full Text] [Related]
7. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
8. Cytokine expression and dendritic cell density in melanoma sentinel nodes.
Botella-Estrada R; Dasí F; Ramos D; Nagore E; Herrero MJ; Giménez J; Fuster C; Sanmartín O; Guillén C; Aliño S
Melanoma Res; 2005 Apr; 15(2):99-106. PubMed ID: 15846142
[TBL] [Abstract][Full Text] [Related]
9. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy.
Li LX; Scolyer RA; Ka VS; McKinnon JG; Shaw HM; McCarthy SW; Thompson JF
Am J Surg Pathol; 2003 Sep; 27(9):1197-202. PubMed ID: 12960803
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
[TBL] [Abstract][Full Text] [Related]
12. FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients.
Ryan M; Crow J; Kahmke R; Fisher SR; Su Z; Lee WT
Am J Otolaryngol; 2014; 35(6):689-94. PubMed ID: 25212103
[TBL] [Abstract][Full Text] [Related]
13. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.
Movassagh M; Spatz A; Davoust J; Lebecque S; Romero P; Pittet M; Rimoldi D; Liénard D; Gugerli O; Ferradini L; Robert C; Avril MF; Zitvogel L; Angevin E
Cancer Res; 2004 Mar; 64(6):2192-8. PubMed ID: 15026362
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.
Sun W; Xu Y; Yang J; Liao Z; Li T; Huang K; Patel P; Yan W; Chen Y
Cancer Commun (Lond); 2020 Nov; 40(11):586-597. PubMed ID: 33025763
[TBL] [Abstract][Full Text] [Related]
15. Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer.
Poindexter NJ; Sahin A; Hunt KK; Grimm EA
Breast Cancer Res; 2004; 6(4):R408-15. PubMed ID: 15217509
[TBL] [Abstract][Full Text] [Related]
16. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma.
Starz H; Balda BR; Krämer KU; Büchels H; Wang H
Cancer; 2001 Jun; 91(11):2110-21. PubMed ID: 11391592
[TBL] [Abstract][Full Text] [Related]
17. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
[TBL] [Abstract][Full Text] [Related]
18. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion.
Haddad FF; Stall A; Messina J; Brobeil A; Ramnath E; Glass LF; Cruse CW; Berman CG; Reintgen DS
Ann Surg Oncol; 1999 Mar; 6(2):144-9. PubMed ID: 10082038
[TBL] [Abstract][Full Text] [Related]
19. Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes.
Den Toom IJ; Bloemena E; van Weert S; Karagozoglu KH; Hoekstra OS; de Bree R
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):961-968. PubMed ID: 27561671
[TBL] [Abstract][Full Text] [Related]
20. CD83(+) dendritic cells and Foxp3(+) regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer.
Kashimura S; Saze Z; Terashima M; Soeta N; Ohtani S; Osuka F; Kogure M; Gotoh M
Gastric Cancer; 2012 Apr; 15(2):144-53. PubMed ID: 22083420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
